Professor Steve Vucic is a clinical academic and internationally recognised researcher in the field of neuroscience with an emphasis on understanding amyotrophic lateral sclerosis (ALS) pathogenesis. His key discoveries relating to identification of “cortical hyperexcitability” as an important pathophysiological mechanism in ALS have transformed the understanding of ALS, resulted in novel therapeutic approaches and led to development of pharmacodynamic biomarkers. In addition, a much-needed diagnostic investigation was developed for ALS, termed threshold tracking transcranial magnetic stimulation (TMS), enabling earlier diagnosis and thereby recruitment into clinical trials.

Professor Vucic has published and presented extensively and has received national and international accolades for his research.